M Mincheff

Summary

Publications

  1. ncbi Naked DNA and adenoviral immunizations for immunotherapy of prostate cancer: a phase I/II clinical trial
    M Mincheff
    American Foundation for Biological Research, Rockville, MD 20852, USA
    Eur Urol 38:208-17. 2000
  2. ncbi In vivo transfection and/or cross-priming of dendritic cells following DNA and adenoviral immunizations for immunotherapy of cancer--changes in peripheral mononuclear subsets and intracellular IL-4 and IFN-gamma lymphokine profile
    M Mincheff
    Biomedical Research Institute, 12111 Parklawn Drive, Rockville, MD 20852, USA
    Crit Rev Oncol Hematol 39:125-32. 2001

Detail Information

Publications2

  1. ncbi Naked DNA and adenoviral immunizations for immunotherapy of prostate cancer: a phase I/II clinical trial
    M Mincheff
    American Foundation for Biological Research, Rockville, MD 20852, USA
    Eur Urol 38:208-17. 2000
    ..The primary objective of the study was to determine the safety of the PSMA vaccine after repeated intradermal injections...
  2. ncbi In vivo transfection and/or cross-priming of dendritic cells following DNA and adenoviral immunizations for immunotherapy of cancer--changes in peripheral mononuclear subsets and intracellular IL-4 and IFN-gamma lymphokine profile
    M Mincheff
    Biomedical Research Institute, 12111 Parklawn Drive, Rockville, MD 20852, USA
    Crit Rev Oncol Hematol 39:125-32. 2001
    ..A panel of changes in the phenotype of peripheral blood lymphocytes and the expression of intra-T-cell lymphokines seems to correlate with clinical improvement...